Chronic Viral and Inflammatory Cardiomyopathy -- Overview on Chronic Viral Cardiomyopathy/Chronic Myocarditis -- Unsolved Medical Issues and New Targets for Further Research in Viral Myocarditis and Dilated Cardiomyopathy -- Viruses -- Frontiers in Viral Diagnostics -- Invited for Debate: Is Virus Persistence a Determinant for Disease Progression? -- Parvovirus B19: The Causative Agent of Dilated Cardiomyopathy or a Harmless Passenger of the Human Myocard? -- Parvovirus B19: A New Emerging Pathogenic Agent of Inflammatory Cardiomyopathy -- Role of Hepatitis C Virus in Cardiomyopathies -- Immunity and Autoimmunity -- Recent Insights into the Role of Host Innate and Acquired Immunity Responses -- The Significance of Autoimmunity in Myocarditis -- The Roles of Immunity and Autoimmunity in Chronic Heart Failure -- Clinical Implications of Anti-cardiac Immunity in Dilated Cardiomyopathy -- Cardiac Remodeling -- Inflammation and Cardiac Remodeling During Viral Myocarditis -- Inflammatory Cardiomyopathy: There Is a Specific Matrix Destruction in the Course of the Disease -- Invited for Debate: Is There a Virus-Specific Matrix Destruction in the Course of Disease in Dilated Cardiomyopathy? -- Diagnosis and Treatment -- New Non-invasive Approaches for the Diagnosis of Cardiomyopathy: Magnetic Resonance Imaging -- New Therapeutics Targets in Chronic Viral Cardiomyopathy -- Myocarditis and Inflammatory Cardiomyopathy: Histomorphological Diagnosis -- Anti-viral Treatment in Patients with Virus-Induced Cardiomyopathy -- Immunosuppressive Treatment of Chronic Non-viral Myocarditis -- Immunoadsorption in Dilated Cardiomyopathy.